Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$830M |
| 2 |
DoorDash
DASH
|
+$667M |
| 3 |
JPMorgan Chase
JPM
|
+$588M |
| 4 |
Netflix
NFLX
|
+$583M |
| 5 |
Dollar Tree
DLTR
|
+$500M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.77B |
| 2 |
Advanced Micro Devices
AMD
|
+$713M |
| 3 |
Danaher
DHR
|
+$709M |
| 4 |
GE Aerospace
GE
|
+$480M |
| 5 |
UnitedHealth
UNH
|
+$451M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Healthcare | 17.32% |
| 3 | Financials | 15.71% |
| 4 | Consumer Discretionary | 15.6% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sherwin-Williams
SHW
$84.1B
| $122M | 0.47% |
+407,786
| New | +$126M |
|
52
Apollo Global Management
APO
$78.4B
| $115M | 0.44% |
+971,224
| New | +$110M |
|
53
Adaptive Biotechnologies
ADPT
$4.15B
| $109M | 0.42% |
29,993,708
| – | – |
|
54
Salesforce
CRM
$171B
| $104M | 0.4% |
+405,135
| New | +$108M |
|
55
Standard BioTools
LAB
$263M
| $104M | 0.4% |
58,651,170
| – | – |
|
56
Oscar Health
OSCR
$9.89B
| $93.8M | 0.36% |
5,928,038
+1,196,036
| +25% | +$22M |
|
57
Procore
PCOR
$9.65B
| $91.1M | 0.35% |
1,374,580
+383,351
| +39% | +$26.6M |
|
58
Allstate
ALL
$64.2B
| $87M | 0.33% |
+545,182
| New | +$90.9M |
|
59
McKesson
MCK
$100B
| $83M | 0.32% |
142,169
-448,411
| -76% | -$250M |
|
60
FIVE9
FIVN
$2.45B
| $76.5M | 0.29% |
1,734,414
-1,717,724
| -50% | -$89.3M |
|
61
NRG Energy
NRG
$23.8B
| $73.5M | 0.28% |
+943,457
| New | +$73.1M |
|
62
Viking Therapeutics
VKTX
$3.95B
| $71.8M | 0.28% |
1,354,450
+259,510
| +24% | +$17M |
|
63
Carvana
CVNA
$76.9B
| $71.3M | 0.27% |
+2,768,105
| New | +$55.7M |
|
64
Insmed
INSM
$27.5B
| $69.4M | 0.27% |
+1,035,970
| New | +$40.2M |
|
65
Pharvaris
PHVS
$2.55B
| $68.7M | 0.26% |
3,653,310
| – | – |
|
66
4D Molecular Therapeutics
FDMT
$875M
| $61.6M | 0.24% |
2,934,914
| – | – |
|
67
Immunovant
IMVT
$9.16B
| $61.3M | 0.24% |
2,320,902
+511,730
| +28% | +$14.6M |
|
68
Vertiv
VRT
$101B
| $59.7M | 0.23% |
689,687
-328,307
| -32% | -$29.9M |
|
69
KKR & Co
KKR
$97.4B
| $57.4M | 0.22% |
545,092
-526,074
| -49% | -$53.6M |
|
70
Ginkgo Bioworks
DNA
$498M
| $47.8M | 0.18% |
3,577,128
| – | – |
|
|
LBPH
71
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $44.8M | 0.17% |
1,658,962
+677,634
| +69% | +$13.4M |
|
72
LPL Financial
LPLA
$28.5B
| $36.3M | 0.14% |
+130,000
| New | +$35.3M |
|
73
Zai Lab
ZLAB
$2.92B
| $35.3M | 0.14% |
2,037,374
-10,755
| -0.5% | -$189K |
|
|
DAWN
74
DELISTED
Day One Biopharmaceuticals
DAWN
| $35.3M | 0.14% |
2,558,563
| – | – |
|
75
Oric Pharmaceuticals
ORIC
$1.47B
| $28.3M | 0.11% |
4,000,000
| – | – |
|
Similar funds
Andreas Halvorsen's Q2 2024 Portfolio in Review
As of Q2 2024, Andreas Halvorsen held 108 positions worth $26B, down 3.1% from $26.9B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Andreas Halvorsen's Q2 2024 filing shows 25 new, 27 increased, 18 reduced and 26 closed positions. Its largest new stake was DoorDash: 5,535,921 shares worth $602M. The largest sale was Visa, an estimated $1.77B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Andreas Halvorsen's largest Q2 2024 buy was DoorDash: 5,535,921 shares worth $602M.
- Andreas Halvorsen added most to Adobe in Q2 2024, an estimated $830M increase.
- Andreas Halvorsen's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $451M.
- Andreas Halvorsen fully exited Visa in Q2 2024, selling an estimated $1.77B.
- Andreas Halvorsen's ten largest holdings make up 41% of its $26B portfolio in Q2 2024.
- Andreas Halvorsen opened 25 new positions and closed 26 in Q2 2024.
- Andreas Halvorsen's portfolio value fell 3.1% quarter-over-quarter to $26B.
Based on Viking Global Investors's 13F filing for Q2 2024, filed 14 Aug 2024.